Skip to main content
INBIOGEN Co., Ltd. (KRX:101140)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,100.00
+650.00 (7.69%)
At close: Mar 6, 2026

INBIOGEN Revenue

INBIOGEN had revenue of 2.15B KRW in the quarter ending September 30, 2025, with 3.18% growth. This brings the company's revenue in the last twelve months to 7.80B, up 21.25% year-over-year. In the year 2024, INBIOGEN had annual revenue of 7.04B with 12.82% growth.

Revenue (ttm)
7.80B
Revenue Growth
+21.25%
P/S Ratio
11.22
Revenue / Employee
190.33M
Employees
41
Market Cap
87.57B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20247.04B800.26M12.82%
Dec 31, 20236.24B-4.18B-40.10%
Dec 31, 202210.42B-61.30M-0.58%
Dec 31, 202110.48B263.11M2.58%
Dec 31, 202010.22B422.51M4.31%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Nature Holdings 501.19B
09WOMEN 45.99B
Uni-Chem 132.03B
Samyang Tongsang 180.93B
HWASEUNG Industries 1,877.53B
Au Brandz Co.,Ltd 48.77B
BAIKSAN Co,. 524.20B
Hwaseung Enterprise 1,652.64B
Revenue Rankings

INBIOGEN News

More News